ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
+6.77%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$31.8B
AUM Growth
+$4.92B
(+18%)
Cap. Flow
+$3.45B
Cap. Flow
% of AUM
10.84%
Top 10 Holdings %
Top 10 Hldgs %
25.98%
Holding
2,274
New
181
Increased
1,795
Reduced
280
Closed
17
Top Buys
| 1 |
Amazon
AMZN
|
+$282M |
| 2 |
Apple
AAPL
|
+$247M |
| 3 |
Microsoft
MSFT
|
+$234M |
| 4 |
IBM
IBM
|
+$132M |
| 5 |
Tesla
TSLA
|
+$109M |
Top Sells
| 1 |
RTX Corp
RTX
|
+$125M |
| 2 |
Carrier Global
CARR
|
+$123M |
| 3 |
Otis Worldwide
OTIS
|
+$110M |
| 4 |
Albemarle
ALB
|
+$59.7M |
| 5 |
Exxon Mobil
XOM
|
+$34M |
Sector Composition
| 1 | Technology | 25.63% |
| 2 | Consumer Discretionary | 15.64% |
| 3 | Communication Services | 10.33% |
| 4 | Financials | 9.6% |
| 5 | Healthcare | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Fulgent Genetics
FLGT
$667M
| $400K | ﹤0.01% |
+4,142
| New | +$400K |
|
1602
Ollie's Bargain Outlet
OLLI
$7.95B
| $400K | ﹤0.01% |
4,595
-68
| -1% | -$5.92K |
|
|
FMTX
1603
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $400K | ﹤0.01% |
14,281
+4,120
| +41% | +$115K |
|
1604
Morningstar
MORN
$10.6B
| $399K | ﹤0.01% |
1,773
+330
| +23% | +$74.3K |
|
1605
Materion
MTRN
$2.29B
| $399K | ﹤0.01% |
6,026
+1,137
| +23% | +$75.3K |
|
|
VRE
1606
Veris Residential
VRE
$1.49B
| $399K | ﹤0.01% |
25,746
+4,860
| +23% | +$75.3K |
|
1607
TechnipFMC
FTI
$16.8B
| $398K | ﹤0.01% |
51,608
-176,427
| -77% | -$1.36M |
|
1608
Enviri
NVRI
$959M
| $398K | ﹤0.01% |
23,227
+4,395
| +23% | +$75.3K |
|
1609
Protagonist Therapeutics
PTGX
$3.59B
| $398K | ﹤0.01% |
15,367
+2,492
| +19% | +$64.5K |
|
1610
Saic
SAIC
$4.75B
| $396K | ﹤0.01% |
4,735
-2,631
| -36% | -$220K |
|
|
KLRS
1611
Kalaris Therapeutics, Inc. Common Stock
KLRS
$85.1M
| $396K | ﹤0.01% |
736
+126
| +21% | +$67.8K |
|
1612
Curtiss-Wright
CW
$18.7B
| $395K | ﹤0.01% |
3,329
-85
| -2% | -$10.1K |
|
1613
G-III Apparel Group
GIII
$1.13B
| $394K | ﹤0.01% |
13,076
+2,470
| +23% | +$74.4K |
|
1614
Park Hotels & Resorts
PK
$2.36B
| $394K | ﹤0.01% |
18,274
-261
| -1% | -$5.63K |
|
1615
ePlus
PLUS
$1.93B
| $394K | ﹤0.01% |
7,904
+1,496
| +23% | +$74.6K |
|
1616
Cassava Sciences
SAVA
$101M
| $393K | ﹤0.01% |
+8,745
| New | +$393K |
|
1617
Innoviva
INVA
$1.25B
| $392K | ﹤0.01% |
32,841
+1,936
| +6% | +$23.1K |
|
1618
Replimune Group
REPL
$468M
| $392K | ﹤0.01% |
12,861
+502
| +4% | +$15.3K |
|
1619
US Physical Therapy
USPH
$1.23B
| $392K | ﹤0.01% |
3,768
+712
| +23% | +$74.1K |
|
1620
Laureate Education
LAUR
$4.09B
| $391K | ﹤0.01% |
28,781
+4,924
| +21% | +$66.9K |
|
|
OPI
1621
Office Properties Income Trust
OPI
$18.7M
| $391K | ﹤0.01% |
14,208
+2,669
| +23% | +$73.5K |
|
1622
FTI Consulting
FCN
$5.23B
| $390K | ﹤0.01% |
2,784
-151
| -5% | -$21.2K |
|
1623
Cactus
WHD
$2.84B
| $390K | ﹤0.01% |
12,723
+2,178
| +21% | +$66.8K |
|
|
ECOL
1624
DELISTED
US Ecology, Inc.
ECOL
| $390K | ﹤0.01% |
9,364
+1,770
| +23% | +$73.7K |
|
1625
Patterson-UTI
PTEN
$2.11B
| $389K | ﹤0.01% |
54,599
+10,268
| +23% | +$73.2K |
|